Skip Navigation

Advertise|Press|Contact|FAQ|About Us


Home » Clinical Trials » Anxiety Disorders

Clinical Trial Details


Research Study Summary

A Phase 1 clinical study for patients with Anxiety Disorder

Research Study Title

Cipralex® for Anxiety Disorders in Adolescents: Clinical and Physiological Changes Associated With Open Label, Flexible-dose Treatment


The primary objective is to examine whether Cipralex® is effective and safe in the treatment of anxiety disorders in youth. The secondary objective is to identify changes in arousal and stress response from pre- to post-treatment with Cipralex® in youth with anxiety disorders.

To Learn more



Both Male and Female


13 to 18 Years

Overall Status


Lead Sponsor

University of Ottawa


46 Months

Facility Type



Both Male and Female ages 13 Years to 18 Years

Inclusion Criteria:

  • Primary diagnosis of (1 or more)

  • Social Phobia

  • Generalized Anxiety Disorder

  • Separation Anxiety Disorder

  • Panic Disorder

  • Comorbid depression allowed

Exclusion Criteria:

  • Unstable medical condition

  • Substance use disorder

  • Current diagnosis of OCD

  • Lifetime diagnosis of developmental delay, pervasive developmental disorder, psychosis

Site Locations (1)

Country State City Zip Facility and Contact
Canada Ontario Ottawa K1Z 7K4 The University of Ottawa Institute of Mental Health Research
Chantelle McEwen, MA
613-722-6521 ext. 6194

Martine Flament, MD
Principal Investigator


Martine Flament, MD
613-722-6521 ext. 6455

NCT ID: NCT01293838

Date Last Changed: February 10, 2011

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.